U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 761 - 770 of 13125 results

Status:
Investigational
Source:
NCT01103349: Phase 2 Interventional Completed Asthma
(2010)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)



Boehringer Ingelheim is developing BI-671800, an orally administered treatment for seasonal allergic rhinitis and asthma. BI-671800 is an antagonist of the PGD2 receptor, CRTH2. PGD2 stimulates bronchoconstriction and allergic airway inflammation in animal models. Inhibition of CRTH2 may reduce airway inflammatory cells, IL -4, -5, -13 production, serum IgE and airway hyper reactivity. Treatment with BI-671800 in poorly controlled asthmatic patients receiving FP was associated with a significant improvement in FEV1. BI-671800 was well tolerated at a total daily dose of 800 mg for 6 weeks.
Status:
Investigational
Source:
NCT03887169: Phase 1/Phase 2 Interventional Completed Pulmonary Alveolar Proteinosis
(2019)
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Homocysteine, an amino acid synthesized intracellularly by removal of the N-methyl group from the essential amino acid methionine. High plasma level of homocysteine is called hyperhomocysteinemia is a clinical biomarker for increased risk of cardiovascular disease, thromboembolic diseases, and myocardial infarction. It was shown, that hyperhomocysteinemia could be an independent risk factor for dementia and Alzheimer's disease. The falling of homocysteine concentrations in response to increasing B-group-vitamin status, have the hope that mental decline, or Alzheimer's disease, could be prevented by dietary modification or food fortification. Besides, homocysteine can behave as an anti-oxidant agent by increasing the antioxidant capacity of the tumor and endothelial cells.
Status:
Investigational
Source:
INN:cromitrile
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Cromitrile is an antiallergic developed by Miles Laboratories Inc. The compound was also shown to possess bronchodilator and anti-inflammatory activity.
Status:
Investigational
Source:
INN:moxadolen
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Moxadolen is tricyclo-[5.2.1.0.2.6endo]decenone derivative. Moxadolen pharmacokinetics were investigated after oral application in male Wistar rats. The compound is extensively absorbed and mainly renally eliminated. Within 60 h, 63% of the activity is recovered in urine and feces. After 12 h 27% of the activity is eliminated (application in polyethylene glycol). The highest total concentration of the activity in the plasma is found after 2 h, the highest of the unchanged drug is found after 1 h. The half-life is 2.9 h.
Status:
Investigational
Source:
INN:dicloralurea [INN]
Source URL:

Class (Stereo):
CHEMICAL (MIXED)

Conditions:

Dicloralurea is a herbicide and veterinary food additive that inhibits methane production in herbicide ruminants. It acts as a growth stimulant and now superseded.
Status:
Investigational
Source:
USAN:Ampyrimine
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Ampyrimine is a diuretic agent.
Status:
Investigational
Source:
INN:metaterol
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Metaterol is a beta-adrenoceptor agonist. It exerts sympathomimetic and broncholytic properties.
Status:
Investigational
Source:
NCT00891241: Phase 1 Interventional Completed Heart Failure
(2009)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Status:
Investigational
Source:
NCT01668147: Phase 1/Phase 2 Interventional Completed Drug Effects
(2012)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Status:
Investigational
Source:
INN:cefuracetime
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Cefuracetime is an impurity of Cefuroxime, which is an antibacterial agent.